These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 1847721

  • 1. Contrasting effects of lisinopril and nifedipine on albuminuria and tubular transport functions in insulin dependent diabetics with nephropathy.
    Holdaas H, Hartmann A, Lien MG, Nilsen L, Jervell J, Fauchald P, Endresen L, Djøseland O, Berg KJ.
    J Intern Med; 1991 Feb; 229(2):163-70. PubMed ID: 1847721
    [Abstract] [Full Text] [Related]

  • 2. Contrasting effects of angiotensin converting inhibitor and alpha-1-antagonist on albuminuria in insulin-dependent diabetes mellitus patients with nephropathy.
    Holdaas H, Hartmann A, Berg KJ, Langberg H, Blystad L, Fauchald P.
    J Intern Med; 1995 Jan; 237(1):63-71. PubMed ID: 7830033
    [Abstract] [Full Text] [Related]

  • 3. Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.
    Crepaldi G, Carta Q, Deferrari G, Mangili R, Navalesi R, Santeusanio F, Spalluto A, Vanasia A, Villa GM, Nosadini R.
    Diabetes Care; 1998 Jan; 21(1):104-10. PubMed ID: 9538979
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomised double-blind study.
    O'Donnell MJ, Rowe BR, Lawson N, Horton A, Gyde OH, Barnett AH.
    J Hum Hypertens; 1993 Aug; 7(4):333-9. PubMed ID: 8410924
    [Abstract] [Full Text] [Related]

  • 5. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
    Salako BL, Finomo FO, Kadiri S, Arije A, Olatosin AO.
    Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
    [Abstract] [Full Text] [Related]

  • 6. Effect of 3 years of antihypertensive therapy on renal structure in type 1 diabetic patients with albuminuria: the European Study for the Prevention of Renal Disease in Type 1 Diabetes (ESPRIT).
    Diabetes; 2001 Apr; 50(4):843-50. PubMed ID: 11289051
    [Abstract] [Full Text] [Related]

  • 7. Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine.
    Agardh CD, Garcia-Puig J, Charbonnel B, Angelkort B, Barnett AH.
    J Hum Hypertens; 1996 Mar; 10(3):185-92. PubMed ID: 8733038
    [Abstract] [Full Text] [Related]

  • 8. Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment.
    Rossing P, Tarnow L, Boelskifte S, Jensen BR, Nielsen FS, Parving HH.
    Diabetes; 1997 Mar; 46(3):481-7. PubMed ID: 9032106
    [Abstract] [Full Text] [Related]

  • 9. Low-dose angiotensin converting enzyme inhibitors: effect on renal function in normo- and hypertensive type 1 diabetic patients.
    Ciavarella A, Mustacchio A, Silletti A, Franchi R, Levorato M, Campieri C, Borgnino LC, Capozzi G, Morotti L, Vannini P.
    Eur J Med; 1992 Sep; 1(5):268-72. PubMed ID: 1341608
    [Abstract] [Full Text] [Related]

  • 10. The natriuretic effect of nifedipine gastrointestinal therapeutic system remains despite the presence of mild-to-moderate renal failure.
    Campo C, Garcia-Vallejo O, Barrios V, Lahera V, Manero M, Esteban E, Rodicio JL, Ruilope LM.
    J Hypertens; 1997 Dec; 15(12 Pt 2):1803-8. PubMed ID: 9488243
    [Abstract] [Full Text] [Related]

  • 11. [Comparison of treatment effects with an angiotensin converting enzyme inhibitor--lisinopril and a calcium blocker--nifedipine retard on urinary albumin excretion in patients with non-complicated essential hypertension].
    Widecka K, Celibała R, Czekalski S.
    Pol Arch Med Wewn; 1995 Feb; 93(2):135-42. PubMed ID: 7479231
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience.
    Parving HH, Rossing P, Hommel E, Smidt UM.
    Am J Kidney Dis; 1995 Jul; 26(1):99-107. PubMed ID: 7611276
    [Abstract] [Full Text] [Related]

  • 13. Short-term effect of angiotensin-converting enzyme inhibitor enalapril in incipient diabetic nephropathy.
    Abu-Romeh SH, Nawaz MK, Ali JH, Al-Suhaili AR, Abu-Jayyab AK.
    Clin Nephrol; 1989 Jan; 31(1):18-21. PubMed ID: 2536602
    [Abstract] [Full Text] [Related]

  • 14. Atrial natriuretic peptide increases albuminuria in type I diabetic patients: evidence for blockade of tubular protein reabsorption.
    Jacobs EM, Vervoort G, Branten AJ, Klasen I, Smits P, Wetzels JF.
    Eur J Clin Invest; 1999 Feb; 29(2):109-15. PubMed ID: 10092997
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.